Abstract
A series of 4(3H)-quinazolinone derivatives with dithiocarbamate side chains were synthesized and tested for their in vitro antitumor activity against human myelogenous leukemia K562 cells. Among them, (3,4-dihydro-2-methyl-4-oxoquinazolin-6-yl)methyl 4-(4-fluorophenyl)piperazine-1-carbodithioate 8q exhibited significant inhibitory activity against K562 cells with IC(50) value of 0.5 microM.
Publication types
-
Research Support, Non-U.S. Gov't
MeSH terms
-
Animals
-
Antineoplastic Agents / chemical synthesis*
-
Antineoplastic Agents / pharmacology
-
Humans
-
Inhibitory Concentration 50
-
K562 Cells
-
Quinazolines / chemical synthesis*
-
Quinazolines / pharmacology
-
Quinazolinones
-
Structure-Activity Relationship
-
Thiocarbamates / chemical synthesis*
-
Thiocarbamates / pharmacology
-
Tumor Cells, Cultured
Substances
-
Antineoplastic Agents
-
Quinazolines
-
Quinazolinones
-
Thiocarbamates
-
4-hydroxyquinazoline